M
Marie-Aude Khuong
Publications - 7
Citations - 266
Marie-Aude Khuong is an academic researcher. The author has contributed to research in topics: Albendazole & Cart. The author has an hindex of 4, co-authored 6 publications receiving 222 citations.
Papers
More filters
Journal ArticleDOI
No Perinatal HIV-1 Transmission From Women With Effective Antiretroviral Therapy Starting Before Conception
Laurent Mandelbrot,Roland Tubiana,Jérôme Le Chenadec,Catherine Dollfus,Albert Faye,Emmanuelle Pannier,Sophie Matheron,Marie-Aude Khuong,Valérie Garrait,Véronique Reliquet,Alain Devidas,Alain Berrebi,Christine Allisy,Christophe Elleau,Cédric Arvieux,Christine Rouzioux,Josiane Warszawski,Stéphane Blanche +17 more
TL;DR: Perinatal HIV-1 transmission is virtually zero in mothers who start ART before conception and maintain suppression of plasma VL.
Journal ArticleDOI
Albendazole Versus Thiabendazole as Therapy for Trichinosis: A Retrospective Study
André Cabié,Olivier Bouchaud,Sandrine Houzé,Marie-Aude Khuong,Catherine Ruggeri,Thierry Ancelle,Sophie Matheron,Jean-Pierre Coulaud +7 more
TL;DR: The immediate efficacy of thiabendazole and albENDazole as therapy for trichinosis was comparable, but albendazoles was better tolerated, and six months after treatment, 16 of the 31 patients who responded to a questionnaire still had symptoms.
Journal ArticleDOI
Visiting one's native country: the risks of nonadherence in HIV-infected sub-Saharan migrants--ANRS VIHVO study.
Sophie Abgrall,Lionel Fugon,Lionel Fugon,Nathalie Lele,Estelle Carde,Michelle Bentata,Olivier Patey,Marie-Aude Khuong,Bruno Spire,Bruno Spire,Patrizia Carrieri,Patrizia Carrieri,Olivier Bouchaud +12 more
TL;DR: Evaluating to what extent travel-related factors may cause adherence failure to antiretroviral therapy in otherwise adherent migrants when traveling back to Africa found owning/renting one’s house in France, singlehood, and HIV status disclosure were correlates of sustained adherence during traveling.
Journal ArticleDOI
Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients.
Alexandre Storto,Benoit Visseaux,Mélanie Bertine,Quentin Le Hingrat,Gilles Collin,Florence Damond,Marie-Aude Khuong,L. Blum,Roland Tubiana,M. Karmochkine,Charles Cazanave,Sophie Matheron,Diane Descamps,Charlotte Charpentier,Anrs Hiv Co Cohort +14 more
TL;DR: A 2-3-fold higher prevalence of MRV in HIV-2 infection among ART-naive patients is observed when a 1% detection threshold of mutations was used compared with a 20% threshold, and the proportion of patients with X4-tropic viruses was twice as high when UDS was used.
Journal ArticleDOI
"Real life" use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study.
Pierre Gantner,Babacar Sylla,Laurence Morand-Joubert,Pierre Frange,Pierre Frange,Karine Lacombe,Marie-Aude Khuong,Claudine Duvivier,Odile Launay,Marina Karmochkine,Cédric Arvieux,Amélie Menard,Lionel Piroth,Ana Canestri,Dominique Trias,Gilles Peytavin,Roland Landman,Jade Ghosn +17 more
TL;DR: HIV-1-infected women receiving RAL during pregnancy between 2008 and 2014 in ten French centers were retrospectively analysed and RAL appears safe and effective in this “real-life” study.